Pubblicazioni

Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo

2024 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Guttman-Yassky, E.; Del Duca, E.; Da Rosa, J. C.; Bar, J.; Ezzedine, K.; Ye, Z.; He, W.; Hyde, C.; Hassan-Zahraee, M.; Yamaguchi, Y.; Peeva, E.

Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers

2022 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Guttman-Yassky, E.; Pavel, A. B.; Diaz, A.; Zhang, N.; Del Duca, E.; Estrada, Y.; King, B.; Banerjee, A.; Banfield, C.; Cox, L. A.; Dowty, M. E.; Page, K.; Vincent, M. S.; Zhang, W.; Zhu, L.; Peeva, E.

Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities

2021 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

He, H.; Del Duca, E.; Diaz, A.; Kim, H. J.; Gay-Mimbrera, J.; Zhang, N.; Wu, J.; Beaziz, J.; Estrada, Y.; Krueger, J. G.; Pavel, A. B.; Ruano, J.; Guttman-Yassky, E.

Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis

2020 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

He, H.; Suryawanshi, H.; Morozov, P.; Gay-Mimbrera, J.; Del Duca, E.; Kim, H. J.; Kameyama, N.; Estrada, Y.; Der, E.; Krueger, J. G.; Ruano, J.; Tuschl, T.; Guttman-Yassky, E.